ORIC Pharmaceuticals Inc.

NASDAQ: ORIC · Real-Time Price · USD
9.72
-0.21 (-2.11%)
At close: Aug 15, 2025, 3:59 PM
9.62
-1.03%
After-hours: Aug 15, 2025, 07:13 PM EDT

ORIC Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-36.35M -30.02M -36.31M -34.57M -31.96M -25.01M -28.33M -25.48M -22.94M -23.95M -20.85M -24.83M -20.29M -23.16M -22.77M -18.43M -21.01M -16.51M
Depreciation & Amortization
310K 302K 304K 270K 272K 261K 263K 257K 259K 253K 247K 221K 247K 251K 229K 217K 222K 229K
Stock-Based Compensation
6.57M 6.55M 5.2M 5.06M 5M 4.96M 3.92M 3.86M 3.83M 3.61M 3.13M 3.29M 4.09M 3.94M 3.5M 3.4M 3.21M 2.74M
Other Working Capital
-532K -575K 1.35M 1.63M -434K -2.41M 1M -277K -211K 1.1M 777K 1.86M -1.58M -536K 132K 703K -1.13M 1.43M
Other Non-Cash Items
-591K -882K -1.63M -1.95M -2.3M -2.4M 1.36M -1.92M -1.25M -861K -580K -370K -252K 42K -1.22M 330K 432K 441K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -3.47M n/a n/a n/a n/a n/a n/a n/a 1.36M n/a n/a n/a
Change in Working Capital
-780K -8.49M 4.38M 2.39M 3.37M -8.17M 1.98M 3.63M -1.03M 311K 2.72M 2.37M -1.73M -3.8M 2.61M 2.34M 928K -1.81M
Operating Cash Flow
-30.84M -32.53M -28.05M -28.8M -25.63M -30.35M -24.27M -19.64M -21.14M -20.63M -15.33M -19.32M -17.78M -22.72M -16.28M -12.14M -16.21M -14.9M
Capital Expenditures
n/a -387K -219K -418K -333K -218K -57K -77K -405K -310K -287K -401K -667K -723K -389K -233K -135K -182K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a -21.02K 57.75K 18.91K 310K 2.08M 284.00 n/a 723K 1.38M n/a n/a 260K
Purchase of Investments
-124.37M -64.66M -34.63M -54.01M -48.89M -114.39M -28.97M -110.99M -55.9M -43.39M -31.63M -61.02M -45.54M -99.94M -36.76M -7.7M n/a -25.17M
Sales Maturities Of Investments
47.5M 87.5M 77.5M 77.5M 67.5M 52.74M 49.99M 53.23M 36.99M 56.48M 60.22M 60.73M n/a 10M 37.5M 43M 82.5M 66M
Other Investing Acitivies
n/a n/a n/a -969K n/a n/a 21.02K -57.75K -18.91K -310K -2.08M -284 -45.54M -723K -1.38M 35.3M 82.5M -260K
Investing Cash Flow
-76.93M 22.45M 42.66M 23.07M 18.28M -61.87M 20.96M -57.83M -19.31M 12.78M 28.3M -685K -46.2M -90.66M 351K 35.07M 82.36M 40.65M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-414K -242K 125.58M n/a n/a 198K 227K n/a 174K n/a -207K 1K 415K 16K 813K -1.41M -281K 16K
Financial Cash Flow
134.3M 11K 575K 126K 816K 125.2M 453K 31K 85.17M n/a 25.19M 1K 415K 16K 813K 48.59M -281K 16K
Net Cash Flow
26.53M -10.07M 15.18M -5.6M -6.53M 32.98M -2.85M -77.44M 44.72M -7.85M 37.76M -20M -63.56M -113.36M -15.12M 71.52M 65.87M 25.76M
Free Cash Flow
-30.84M -32.53M -28.27M -29.21M -25.96M -30.57M -24.55M -19.72M -21.55M -20.94M -15.62M -19.72M -18.44M -23.44M -16.67M -12.38M -16.35M -15.08M